Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

BACKGROUND: Primary retroperitoneal lymph node dissection (RPLND) ultimately lost its role as the standard management of clinical stage (CS) 1 nonseminomatous (NS) testicular germ cell tumours (GCTs) in Europe when the European Germ Cell Cancer Consensus Group released their recommendations in 2008....

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Urol
Autores principales: Dieckmann, K.-P., Anheuser, P., Kulejewski, M., Gehrckens, R., Feyerabend, B.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204050/
https://ncbi.nlm.nih.gov/pubmed/30367648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0412-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares